Based on a previous study from our lab, we postulated that the methylation of VEZT promoter was different in gastric carcinoma patients and healthy controls; we used online bioinformatics software to analyze the promoter region and methylation status of the VEZT gene (Figure 1A). This evidence concerns the gene VEZT and gastric carcinoma.